{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:28:26Z","timestamp":1791919706008,"version":"4.3.4"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,5,10]],"date-time":"2015-05-10T00:00:00Z","timestamp":1431216000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s40478-015-0204-4","type":"journal-article","created":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T04:26:30Z","timestamp":1431145590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":122,"title":["Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau"],"prefix":"10.1186","volume":"3","author":[{"given":"Katja","family":"Hochgr\u00e4fe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Sydow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorthe","family":"Matenia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cadinu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"K\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Petrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Pickhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Goll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Morellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eckhard","family":"Mandelkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva-Maria","family":"Mandelkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,10]]},"reference":[{"key":"204_CR1","doi-asserted-by":"publisher","first-page":"a011460","DOI":"10.1101\/cshperspect.a011460","volume":"2","author":"D Selkoe","year":"2012","unstructured":"Selkoe D, Mandelkow E, Holtzman D (2012) Deciphering Alzheimer disease. Cold Spring Harb Perspect Med 2:a011460, doi: 10.1101\/cshperspect.a011460","journal-title":"Cold Spring Harb Perspect Med"},{"key":"204_CR2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JAD-122140","volume":"35","author":"SG Di Santo","year":"2013","unstructured":"Di Santo SG, Prinelli F, Adorni F, Caltagirone C, Musicco M (2013) A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 35:349\u2013361, doi: 10.3233\/JAD-122140","journal-title":"J Alzheimer\u2019s Dis"},{"key":"204_CR3","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov 10:698\u2013712, doi: 10.1038\/nrd3505","journal-title":"Nat Rev Drug Discov"},{"key":"204_CR4","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.bcp.2013.12.008","volume":"88","author":"CM Wischik","year":"2014","unstructured":"Wischik CM, Harrington CR, Storey JM (2014) Tau-aggregation inhibitor therapy for Alzheimer\u2019s disease. Biochem Pharmacol 88:529\u2013539, doi: 10.1016\/j.bcp.2013.12.008","journal-title":"Biochem Pharmacol"},{"key":"204_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/ana.410410106","volume":"41","author":"T Gomez-Isla","year":"1997","unstructured":"Gomez-Isla T, Hollister R, West H, Mui S, Growdon JH, Petersen RC, Parisi JE, Hyman BT (1997) Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer\u2019s disease. Ann Neurol 41:17\u201324, doi: 10.1002\/ana.410410106","journal-title":"Ann Neurol"},{"key":"204_CR6","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1212\/01.WNL.0000115115.98960.37","volume":"62","author":"M Ingelsson","year":"2004","unstructured":"Ingelsson M, Fukumoto H, Newell KL, Growdon JH, Hedley-Whyte ET, Frosch MP, Albert MS, Hyman BT, Irizarry MC (2004) Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62:925\u2013931","journal-title":"Neurology"},{"key":"204_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, Hansen LA, Katzman R (1991) Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30:572\u2013580, doi: 10.1002\/ana.410300410","journal-title":"Ann Neurol"},{"key":"204_CR8","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neuron.2007.01.010","volume":"53","author":"Y Yoshiyama","year":"2007","unstructured":"Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, Maeda J, Suhara T, Trojanowski JQ, Lee VM (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron 53:337\u2013351, doi:S0896-6273(07)00030-X","journal-title":"Neuron"},{"key":"204_CR9","doi-asserted-by":"crossref","first-page":"9340","DOI":"10.1523\/JNEUROSCI.22-21-09340.2002","volume":"22","author":"B Allen","year":"2002","unstructured":"Allen B, Ingram E, Takao M, Smith MJ, Jakes R, Virdee K, Yoshida H, Holzer M, Craxton M, Emson PC, Atzori C, Migheli A, Crowther RA, Ghetti B, Spillantini MG, Goedert M (2002) Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J Neurosci 22:9340\u20139351, doi:22\/21\/9340","journal-title":"J Neurosci"},{"key":"204_CR10","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2353\/ajpath.2006.060002","volume":"169","author":"K Schindowski","year":"2006","unstructured":"Schindowski K, Bretteville A, Leroy K, Begard S, Brion JP, Hamdane M, Buee L (2006) Alzheimer\u2019s disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits. Am J Pathol 169:599\u2013616, doi:S0002-9440(10)62740-X","journal-title":"Am J Pathol"},{"key":"204_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/78078","volume":"25","author":"J Lewis","year":"2000","unstructured":"Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Paul Murphy M, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin WL, Yen SH, Dickson DW, Davies P, Hutton M (2000) Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein. Nat Genet 25:402\u2013405, doi: 10.1038\/78078","journal-title":"Nat Genet"},{"key":"204_CR12","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1126\/science.1113694","volume":"309","author":"K Santacruz","year":"2005","unstructured":"Santacruz K, Lewis J, Spires T, Paulson J, Kotilinek L, Ingelsson M, Guimaraes A, DeTure M, Ramsden M, McGowan E, Forster C, Yue M, Orne J, Janus C, Mariash A, Kuskowski M, Hyman B, Hutton M, Ashe KH (2005) Tau suppression in a neurodegenerative mouse model improves memory function. Science 309:476\u2013481, doi:309\/5733\/476","journal-title":"Science"},{"key":"204_CR13","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1074\/jbc.M409876200","volume":"280","author":"D Terwel","year":"2005","unstructured":"Terwel D, Lasrado R, Snauwaert J, Vandeweert E, Van Haesendonck C, Borghgraef P, Van Leuven F (2005) Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R\/2\u00a0N transgenic mice. J Biol Chem 280:3963\u20133973, doi: 10.1074\/jbc.M409876200","journal-title":"J Biol Chem"},{"key":"204_CR14","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1523\/JNEUROSCI.5245-10.2011","volume":"31","author":"A Sydow","year":"2011","unstructured":"Sydow A, Van der Jeugd A, Zheng F, Ahmed T, Balschun D, Petrova O, Drexler D, Zhou L, Rune G, Mandelkow E, D\u2019Hooge R, Alzheimer C, Mandelkow EM (2011) Tau-induced defects in synaptic plasticity, learning, and memory are reversible in transgenic mice after switching off the toxic Tau mutant. J Neurosci 31:2511\u20132525, doi:31\/7\/2511","journal-title":"J Neurosci"},{"key":"204_CR15","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00401-012-0987-3","volume":"123","author":"A Van der Jeugd","year":"2012","unstructured":"Van der Jeugd A, Hochgrafe K, Ahmed T, Decker JM, Sydow A, Hofmann A, Wu D, Messing L, Balschun D, D\u2019Hooge R, Mandelkow EM (2012) Cognitive defects are reversible in inducible mice expressing pro-aggregant full-length human Tau. Acta Neuropathol 123:787\u2013805, doi: 10.1007\/s00401-012-0987-3","journal-title":"Acta Neuropathol"},{"key":"204_CR16","doi-asserted-by":"publisher","first-page":"31755","DOI":"10.1074\/jbc.M705282200","volume":"282","author":"K Eckermann","year":"2007","unstructured":"Eckermann K, Mocanu MM, Khlistunova I, Biernat J, Nissen A, Hofmann A, Schonig K, Bujard H, Haemisch A, Mandelkow E, Zhou L, Rune G, Mandelkow EM (2007) The beta-propensity of Tau determines aggregation and synaptic loss in inducible mouse models of tauopathy. J Biol Chem 282:31755\u201331765, doi:M705282200","journal-title":"J Biol Chem"},{"key":"204_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1523\/JNEUROSCI.2824-07.2008","volume":"28","author":"MM Mocanu","year":"2008","unstructured":"Mocanu MM, Nissen A, Eckermann K, Khlistunova I, Biernat J, Drexler D, Petrova O, Schonig K, Bujard H, Mandelkow E, Zhou L, Rune G, Mandelkow EM (2008) The potential for beta-structure in the repeat domain of tau protein determines aggregation, synaptic decay, neuronal loss, and coassembly with endogenous Tau in inducible mouse models of tauopathy. J Neurosci 28:737\u2013748, doi:28\/3\/737","journal-title":"J Neurosci"},{"key":"204_CR18","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1086\/302256","volume":"64","author":"P Rizzu","year":"1999","unstructured":"Rizzu P, Van Swieten JC, Joosse M, Hasegawa M, Stevens M, Tibben A, Niermeijer MF, Hillebrand M, Ravid R, Oostra BA, Goedert M, van Duijn CM, Heutink P (1999) High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in the Netherlands. Am J Hum Genet 64:414\u2013421, doi: 10.1086\/302256","journal-title":"Am J Hum Genet"},{"key":"204_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1097\/nen.0b013e31802c39a4","volume":"66","author":"JC Van Swieten","year":"2007","unstructured":"Van Swieten JC, Bronner IF, Azmani A, Severijnen LA, Kamphorst W, Ravid R, Rizzu P, Willemsen R, Heutink P (2007) The DeltaK280 mutation in MAP tau favors exon 10 skipping in vivo. J Neuropathol Exp Neurol 66:17\u201325, doi:10.1097\/nen.0b013e31802c39a400005072-200701000-00003","journal-title":"J Neuropathol Exp Neurol"},{"key":"204_CR20","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.neurobiolaging.2007.07.013","volume":"30","author":"P Momeni","year":"2009","unstructured":"Momeni P, Pittman A, Lashley T, Vandrovcova J, Malzer E, Luk C, Hulette C, Lees A, Revesz T, Hardy J, de Silva R (2009) Clinical and pathological features of an Alzheimer\u2019s disease patient with the MAPT Delta K280 mutation. Neurobiol Aging 30:388\u2013393, doi: 10.1016\/j.neurobiolaging.2007.07.013","journal-title":"Neurobiol Aging"},{"key":"204_CR21","doi-asserted-by":"publisher","first-page":"4135","DOI":"10.1021\/jm3017317","volume":"56","author":"B Bulic","year":"2013","unstructured":"Bulic B, Pickhardt M, Mandelkow E (2013) Progress and developments in tau aggregation inhibitors for Alzheimer disease. J Med Chem 56:4135\u20134155, doi: 10.1021\/jm3017317","journal-title":"J Med Chem"},{"key":"204_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2007.03.056","volume":"358","author":"A Crowe","year":"2007","unstructured":"Crowe A, Ballatore C, Hyde E, Trojanowski JQ, Lee VM (2007) High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation. Biochem Biophys Res Commun 358:1\u20136, doi: 10.1016\/j.bbrc.2007.03.056","journal-title":"Biochem Biophys Res Commun"},{"key":"204_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2174\/1567205053585891","volume":"2","author":"M Pickhardt","year":"2005","unstructured":"Pickhardt M, von Bergen M, Gazova Z, Hascher A, Biernat J, Mandelkow EM, Mandelkow E (2005) Screening for inhibitors of tau polymerization. Curr Alzheimer Res 2:219\u2013226","journal-title":"Curr Alzheimer Res"},{"key":"204_CR24","doi-asserted-by":"publisher","first-page":"7614","DOI":"10.1074\/jbc.M408714200","volume":"280","author":"S Taniguchi","year":"2005","unstructured":"Taniguchi S, Suzuki N, Masuda M, Hisanaga S, Iwatsubo T, Goedert M, Hasegawa M (2005) Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J Biol Chem 280:7614\u20137623, doi:M408714200","journal-title":"J Biol Chem"},{"key":"204_CR25","doi-asserted-by":"publisher","first-page":"11213","DOI":"10.1073\/pnas.93.20.11213","volume":"93","author":"CM Wischik","year":"1996","unstructured":"Wischik CM, Edwards PC, Lai RY, Roth M, Harrington CR (1996) Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci U S A 93:11213\u201311218","journal-title":"Proc Natl Acad Sci U S A"},{"key":"204_CR26","doi-asserted-by":"publisher","first-page":"11109","DOI":"10.1523\/JNEUROSCI.0895-12.2012","volume":"32","author":"EM Sontag","year":"2012","unstructured":"Sontag EM, Lotz GP, Agrawal N, Tran A, Aron R, Yang G, Necula M, Lau A, Finkbeiner S, Glabe C, Marsh JL, Muchowski PJ, Thompson LM (2012) Methylene blue modulates huntingtin aggregation intermediates and is protective in Huntington\u2019s disease models. J Neurosci 32:11109\u201311119, doi: 10.1523\/JNEUROSCI.0895-12.2012","journal-title":"J Neurosci"},{"key":"204_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1111\/j.1440-1789.2009.01089.x","volume":"30","author":"T Arai","year":"2010","unstructured":"Arai T, Hasegawa M, Nonoka T, Kametani F, Yamashita M, Hosokawa M, Niizato K, Tsuchiya K, Kobayashi Z, Ikeda K, Yoshida M, Onaya M, Fujishiro H, Akiyama H (2010) Phosphorylated and cleaved TDP-43 in ALS, FTLD and other neurodegenerative disorders and in cellular models of TDP-43 proteinopathy. Neuropathology 30:170\u2013181, doi: 10.1111\/j.1440-1789.2009.01089.x","journal-title":"Neuropathology"},{"key":"204_CR28","doi-asserted-by":"publisher","first-page":"8850","DOI":"10.1021\/bi700411k","volume":"46","author":"M Necula","year":"2007","unstructured":"Necula M, Breydo L, Milton S, Kayed R, van der Veer WE, Tone P, Glabe CG (2007) Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization. Biochemistry 46:8850\u20138860, doi: 10.1021\/bi700411k","journal-title":"Biochemistry"},{"key":"204_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bbadis.2012.09.005","volume":"1832","author":"P Cavaliere","year":"2013","unstructured":"Cavaliere P, Torrent J, Prigent S, Granata V, Pauwels K, Pastore A, Rezaei H, Zagari A (2013) Binding of methylene blue to a surface cleft inhibits the oligomerization and fibrillization of prion protein. Biochim Biophys Acta 1832:20\u201328, doi: 10.1016\/j.bbadis.2012.09.005","journal-title":"Biochim Biophys Acta"},{"key":"204_CR30","doi-asserted-by":"crossref","unstructured":"Schirmer RH, Adler H, Pickhardt M, Mandelkow E (2011) \u201cLest we forget you--methylene blue\u2026\u201d. Neurobiol Aging 32:2325 e2327-2316. doi:10.1016\/j.neurobiolaging.2010.12.012S0197-4580(10)00529-4","DOI":"10.1016\/j.neurobiolaging.2010.12.012"},{"key":"204_CR31","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.bcp.2009.04.034","volume":"78","author":"M Oz","year":"2009","unstructured":"Oz M, Lorke DE, Petroianu GA (2009) Methylene blue and Alzheimer\u2019s disease. Biochem Pharmacol 78:927\u2013932, doi:10.1016\/j.bcp.2009.04.034S0006-2952(09)00335-9","journal-title":"Biochem Pharmacol"},{"key":"204_CR32","volume-title":"O3-04-07: Tau aggregation inhibitor (TAI) therapy with rember\u2122 arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks. Paper presented at the Alzheimer\u2019s Association International Conference","author":"CM Wischik","year":"2008","unstructured":"Wischik CM, Bentham P, Wischik DJ, Seng KM (2008) O3-04-07: Tau aggregation inhibitor (TAI) therapy with rember\u2122 arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks. Paper presented at the Alzheimer\u2019s Association International Conference. Alzheimer\u2019s Association International Conference, Chicago IL, United States"},{"key":"204_CR33","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1124\/jpet.114.219352","volume":"352","author":"TC Baddeley","year":"2015","unstructured":"Baddeley TC, McCaffrey J, MDS J, Cheung JK, Melis V, Horsley D, Harrington CR, Wischik CM (2015) Complex disposition of methylthioninium redox forms determines efficacy in tau aggregation inhibitor therapy for Alzheimer\u2018s disease. J Pharmacol Exp Ther 352:110\u2013118, doi:10.1124\/jpet.114.219352","journal-title":"J Pharmacol Exp Ther"},{"key":"204_CR34","volume-title":"TauRx.com About LMTX\u2122 for Alzheimer\u2019s","author":"C Wischik","year":"2014","unstructured":"Wischik C, Siew Choon T, Say Way S, Logan S (2014) TauRx.com About LMTX\u2122 for Alzheimer\u2019s. TauRx Therapeutics Ltd, TauRx Therapeutics Ltd. 3, Shenton Way, #21-04 Shenton House Singapore 068805 Republic of Singapore, and TauRx Research Facility Liberty Building Foresterhill Road Aberdeen AB25 2ZP United Kingdom"},{"key":"204_CR35","doi-asserted-by":"publisher","first-page":"3587","DOI":"10.1093\/hmg\/dds190","volume":"21","author":"C Fatouros","year":"2012","unstructured":"Fatouros C, Pir GJ, Biernat J, Koushika SP, Mandelkow E, Mandelkow EM, Schmidt E, Baumeister R (2012) Inhibition of tau aggregation in a novel Caenorhabditis elegans model of tauopathy mitigates proteotoxicity. Hum Mol Genet 21:3587\u20133603, doi: 10.1093\/hmg\/dds190","journal-title":"Hum Mol Genet"},{"key":"204_CR36","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.nbd.2010.03.023","volume":"39","author":"F Van Bebber","year":"2010","unstructured":"Van Bebber F, Paquet D, Hruscha A, Schmid B, Haass C (2010) Methylene blue fails to inhibit Tau and polyglutamine protein dependent toxicity in zebrafish. Neurobiol Dis 39:265\u2013271, doi:10.1016\/j.nbd.2010.03.023 S0969-9961(10)00095-1","journal-title":"Neurobiol Dis"},{"key":"204_CR37","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00213-008-1394-2","volume":"202","author":"S Deiana","year":"2009","unstructured":"Deiana S, Harrington CR, Wischik CM, Riedel G (2009) Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine. Psychopharmacology (Berl) 202:53\u201365, doi: 10.1007\/s00213-008-1394-2","journal-title":"Psychopharmacology (Berl)"},{"key":"204_CR38","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1750-3639.2010.00430.x","volume":"21","author":"DX Medina","year":"2011","unstructured":"Medina DX, Caccamo A, Oddo S (2011) Methylene blue reduces abeta levels and rescues early cognitive deficit by increasing proteasome activity. Brain Pathol 21:140\u2013149, doi:10.1111\/j.1750-3639.2010.00430.x BPA430","journal-title":"Brain Pathol"},{"key":"204_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/1750-1326-5-45","volume":"5","author":"JC O\u2019Leary 3rd","year":"2010","unstructured":"O\u2019Leary JC 3rd, Li Q, Marinec P, Blair LJ, Congdon EE, Johnson AG, Jinwal UK, Koren J, Jones JR 3rd, Kraft C, Peters M, Abisambra JF, Duff KE, Weeber EJ, Gestwicki JE, Dickey CA (2010) Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden. Mol Neurodegener 5:45, doi:10.1186\/1750-1326-5-451750-1326-5-45","journal-title":"Mol Neurodegener"},{"key":"204_CR40","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.neuroscience.2011.12.047","volume":"209","author":"JN Audet","year":"2012","unstructured":"Audet JN, Soucy G, Julien JP (2012) Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models. Neuroscience 209:136\u2013143, doi: 10.1016\/j.neuroscience.2011.12.047","journal-title":"Neuroscience"},{"key":"204_CR41","doi-asserted-by":"publisher","first-page":"e23141","DOI":"10.1371\/journal.pone.0023141","volume":"6","author":"R Lougheed","year":"2011","unstructured":"Lougheed R, Turnbull J (2011) Lack of effect of methylene blue in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. PLoS One 6:e23141, doi:10.1371\/journal.pone.0023141 PONE-D-10-05993","journal-title":"PLoS One"},{"key":"204_CR42","doi-asserted-by":"publisher","first-page":"e52389","DOI":"10.1371\/journal.pone.0052389","volume":"7","author":"M Hosokawa","year":"2012","unstructured":"Hosokawa M, Arai T, Masuda-Suzukake M, Nonaka T, Yamashita M, Akiyama H, Hasegawa M (2012) Methylene blue reduced abnormal tau accumulation in P301L tau transgenic mice. PLoS One 7:e52389, doi: 10.1371\/journal.pone.0052389","journal-title":"PLoS One"},{"key":"204_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.neulet.2014.01.013","volume":"562C","author":"TL Spires-Jones","year":"2014","unstructured":"Spires-Jones TL, Friedman T, Pitstick R, Polydoro M, Roe A, Carlson GA, Hyman BT (2014) Methylene blue does not reverse existing neurofibrillary tangle pathology in the rTg4510 mouse model of tauopathy. Neurosci Lett 562C:63\u201368, doi: 10.1016\/j.neulet.2014.01.013","journal-title":"Neurosci Lett"},{"key":"204_CR44","doi-asserted-by":"crossref","unstructured":"Congdon EE, Wu JW, Myeku N, Figueroa YH, Herman M, Marinec PS, Gestwicki JE, Dickey CA, Yu WH, Duff KE (2012) Methylthioninium chloride (methylene blue) induces autophagy and attenuates tauopathy in vitro and in vivo. Autophagy 8:609-622. doi:10.4161\/auto.1904819048","DOI":"10.4161\/auto.19048"},{"key":"204_CR45","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.chembiol.2012.07.026","volume":"19","author":"Y Miyata","year":"2012","unstructured":"Miyata Y, Rauch JN, Jinwal UK, Thompson AD, Srinivasan S, Dickey CA, Gestwicki JE (2012) Cysteine reactivity distinguishes redox sensing by the heat-inducible and constitutive forms of heat shock protein 70. Chem Biol 19:1391\u20131399, doi: 10.1016\/j.chembiol.2012.07.026","journal-title":"Chem Biol"},{"key":"204_CR46","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1128\/AAC.00773-07","volume":"52","author":"K Buchholz","year":"2008","unstructured":"Buchholz K, Schirmer RH, Eubel JK, Akoachere MB, Dandekar T, Becker K, Gromer S (2008) Interactions of methylene blue with human disulfide reductases and their orthologues from Plasmodium falciparum. Antimicrob Agents Chemother 52:183\u2013191, doi: 10.1128\/AAC.00773-07","journal-title":"Antimicrob Agents Chemother"},{"key":"204_CR47","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1126\/science.274.5293.1678","volume":"274","author":"M Mayford","year":"1996","unstructured":"Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER (1996) Control of memory formation through regulated expression of a CaMKII transgene. Science 274:1678\u20131683","journal-title":"Science"},{"key":"204_CR48","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/0165-0270(84)90007-4","volume":"11","author":"R Morris","year":"1984","unstructured":"Morris R (1984) Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47\u201360, doi:0165-0270(84)90007-4","journal-title":"J Neurosci Methods"},{"key":"204_CR49","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/(SICI)1097-4547(19990315)55:6<713::AID-JNR6>3.0.CO;2-G","volume":"55","author":"GA Jicha","year":"1999","unstructured":"Jicha GA, Berenfeld B, Davies P (1999) Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer\u2019s disease. J Neurosci Res 55:713\u2013723","journal-title":"J Neurosci Res"},{"key":"204_CR50","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1007\/s12035-012-8379-1","volume":"47","author":"K Hochgr\u00e4fe","year":"2013","unstructured":"Hochgr\u00e4fe K, Mandelkow EM (2013) Making the brain glow: in vivo bioluminescence imaging to study neurodegeneration. Mol Neurobiol 47:868\u2013882, doi: 10.1007\/s12035-012-8379-1","journal-title":"Mol Neurobiol"},{"key":"204_CR51","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1021\/bi981874p","volume":"38","author":"A Schneider","year":"1999","unstructured":"Schneider A, Biernat J, von Bergen M, Mandelkow E, Mandelkow EM (1999) Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Biochemistry 38:3549\u20133558, doi: 10.1021\/bi981874p","journal-title":"Biochemistry"},{"key":"204_CR52","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/med.20177","volume":"31","author":"M Oz","year":"2011","unstructured":"Oz M, Lorke DE, Hasan M, Petroianu GA (2011) Cellular and molecular actions of Methylene Blue in the nervous system. Med Res Rev 31:93\u2013117, doi: 10.1002\/med.20177","journal-title":"Med Res Rev"},{"key":"204_CR53","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1074\/jbc.M507753200","volume":"281","author":"I Khlistunova","year":"2006","unstructured":"Khlistunova I, Biernat J, Wang Y, Pickhardt M, von Bergen M, Gazova Z, Mandelkow E, Mandelkow EM (2006) Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. J Biol Chem 281:1205\u20131214, doi:M507753200","journal-title":"J Biol Chem"},{"key":"204_CR54","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s002280000124","volume":"56","author":"C Peter","year":"2000","unstructured":"Peter C, Hongwan D, Kupfer A, Lauterburg BH (2000) Pharmacokinetics and organ distribution of intravenous and oral methylene blue. Eur J Clin Pharmacol 56:247\u2013250","journal-title":"Eur J Clin Pharmacol"},{"key":"204_CR55","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00228-008-0563-x","volume":"65","author":"I Walter-Sack","year":"2009","unstructured":"Walter-Sack I, Rengelshausen J, Oberwittler H, Burhenne J, Mueller O, Meissner P, Mikus G (2009) High absolute bioavailability of methylene blue given as an aqueous oral formulation. Eur J Clin Pharmacol 65:179\u2013189, doi: 10.1007\/s00228-008-0563-x","journal-title":"Eur J Clin Pharmacol"},{"key":"204_CR56","unstructured":"U.S. Food and Drug Administration (2005) Guidance for Industry, Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. http:\/\/www.fda.gov\/downloads\/drugs\/guidancecomplianceregulatoryinformation\/guidances\/ucm078932.pdf."},{"key":"204_CR57","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S0962-8924(98)01368-3","volume":"8","author":"EM Mandelkow","year":"1998","unstructured":"Mandelkow EM, Mandelkow E (1998) Tau in Alzheimer\u2019s disease. Trends Cell Biol 8:425\u2013427, doi:S0962-8924(98)01368-3","journal-title":"Trends Cell Biol"},{"key":"204_CR58","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1523\/JNEUROSCI.4674-06.2007","volume":"27","author":"E Thies","year":"2007","unstructured":"Thies E, Mandelkow EM (2007) Missorting of tau in neurons causes degeneration of synapses that can be rescued by the kinase MARK2\/Par-1. J Neurosci 27:2896\u20132907, doi: 10.1523\/JNEUROSCI.4674-06.2007","journal-title":"J Neurosci"},{"key":"204_CR59","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.tins.2014.08.004","volume":"37","author":"H Zempel","year":"2014","unstructured":"Zempel H, Mandelkow E (2014) Lost after translation: missorting of Tau protein and consequences for Alzheimer disease. Trends Neurosci 37:721\u2013732, doi: 10.1016\/j.tins.2014.08.004","journal-title":"Trends Neurosci"},{"key":"204_CR60","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","volume":"68","author":"BR Hoover","year":"2010","unstructured":"Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan LL, Ashe KH, Liao D (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron 68:1067\u20131081, doi: 10.1016\/j.neuron.2010.11.030","journal-title":"Neuron"},{"key":"204_CR61","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1073\/pnas.97.10.5129","volume":"97","author":"M Von Bergen","year":"2000","unstructured":"Von Bergen M, Friedhoff P, Biernat J, Heberle J, Mandelkow EM, Mandelkow E (2000) Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc Natl Acad Sci U S A 97:5129\u20135134, doi:97\/10\/5129","journal-title":"Proc Natl Acad Sci U S A"},{"key":"204_CR62","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1093\/hmg\/ddu080","volume":"23","author":"C Stack","year":"2014","unstructured":"Stack C, Jainuddin S, Elipenahli C, Gerges M, Starkova N, Starkov AA, Jove M, Portero-Otin M, Launay N, Pujol A, Kaidery NA, Thomas B, Tampellini D, Beal MF, Dumont M (2014) Methylene blue upregulates Nrf2\/ARE genes and prevents tau-related neurotoxicity. Hum Mol Genet 23:3716\u20133732, doi: 10.1093\/hmg\/ddu080","journal-title":"Hum Mol Genet"},{"key":"204_CR63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0021050","volume":"6","author":"H Takeuchi","year":"2011","unstructured":"Takeuchi H, Iba M, Inoue H, Higuchi M, Takao K, Tsukita K, Karatsu Y, Iwamoto Y, Miyakawa T, Suhara T, Trojanowski JQ, Lee VM, Takahashi R (2011) P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating. PLoS One 6, e21050, doi: 10.1371\/journal.pone.0021050","journal-title":"PLoS One"},{"key":"204_CR64","doi-asserted-by":"publisher","first-page":"a006221","DOI":"10.1101\/cshperspect.a006221","volume":"2","author":"K Blennow","year":"2012","unstructured":"Blennow K, Zetterberg H, Fagan AM (2012) Fluid biomarkers in Alzheimer disease. Cold Spring Harb Perspect Med 2:a006221, doi: 10.1101\/cshperspect.a006221","journal-title":"Cold Spring Harb Perspect Med"},{"key":"204_CR65","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","volume":"80","author":"CR Jack Jr","year":"2013","unstructured":"Jack CR Jr, Holtzman DM (2013) Biomarker modeling of Alzheimer\u2019s disease. Neuron 80:1347\u20131358, doi: 10.1016\/j.neuron.2013.12.003","journal-title":"Neuron"},{"key":"204_CR66","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1083\/jcb.118.3.573","volume":"118","author":"H Wille","year":"1992","unstructured":"Wille H, Drewes G, Biernat J, Mandelkow EM, Mandelkow E (1992) Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J Cell Biol 118:573\u2013584","journal-title":"J Cell Biol"},{"key":"204_CR67","doi-asserted-by":"publisher","first-page":"10252","DOI":"10.1073\/pnas.0703676104","volume":"104","author":"BJ Wang","year":"2007","unstructured":"Wang BJ, Pickhardt M, Mandelkow E, Mandelkow EM (2007) Stepwise proteolysis liberates tau fragments that nucleate the Alzheimer-like aggregation of full-length tau in a neuronal cell model. Proc Natl Acad Sci U S A 104:10252\u201310257, doi: 10.1073\/pnas.0703676104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"204_CR68","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1021\/bi0521543","volume":"45","author":"S Jeganathan","year":"2006","unstructured":"Jeganathan S, von Bergen M, Brutlach H, Steinhoff HJ, Mandelkow E (2006) Global hairpin folding of tau in solution. Biochemistry 45:2283\u20132293, doi: 10.1021\/bi0521543","journal-title":"Biochemistry"},{"key":"204_CR69","doi-asserted-by":"publisher","first-page":"4371","DOI":"10.1111\/febs.12250","volume":"280","author":"K Hochgr\u00e4fe","year":"2013","unstructured":"Hochgr\u00e4fe K, Sydow A, Mandelkow EM (2013) Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of Tau pathology. Febs J 280:4371\u20134381, doi: 10.1111\/febs.12250","journal-title":"Febs J"},{"key":"204_CR70","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4103\/0970-9185.74599","volume":"26","author":"PR Ginimuge","year":"2010","unstructured":"Ginimuge PR, Jyothi SD (2010) Methylene blue: revisited. J Anaesthesiol, Clin Pharmacol 26:517\u2013520","journal-title":"J Anaesthesiol, Clin Pharmacol"},{"key":"204_CR71","doi-asserted-by":"publisher","first-page":"3511","DOI":"10.1002\/anie.201208290","volume":"52","author":"E Akoury","year":"2013","unstructured":"Akoury E, Pickhardt M, Gajda M, Biernat J, Mandelkow E, Zweckstetter M (2013) Mechanistic basis of phenothiazine-driven inhibition of Tau aggregation. Angew Chem Int Ed Engl 52:3511\u20133515, doi: 10.1002\/anie.201208290","journal-title":"Angew Chem Int Ed Engl"},{"key":"204_CR72","doi-asserted-by":"publisher","first-page":"11024","DOI":"10.1074\/jbc.M112.436006","volume":"288","author":"A Crowe","year":"2013","unstructured":"Crowe A, James MJ, Lee VM, Smith AB 3rd, Trojanowski JQ, Ballatore C, Brunden KR (2013) Aminothienopyridazines and methylene blue affect Tau fibrillization via cysteine oxidation. J Biol Chem 288:11024\u201311037, doi: 10.1074\/jbc.M112.436006","journal-title":"J Biol Chem"},{"key":"204_CR73","doi-asserted-by":"publisher","first-page":"12079","DOI":"10.1523\/JNEUROSCI.3345-09.2009","volume":"29","author":"UK Jinwal","year":"2009","unstructured":"Jinwal UK, Miyata Y, Koren J 3rd, Jones JR, Trotter JH, Chang L, O\u2019Leary J, Morgan D, Lee DC, Shults CL, Rousaki A, Weeber EJ, Zuiderweg ER, Gestwicki JE, Dickey CA (2009) Chemical manipulation of hsp70 ATPase activity regulates tau stability. J Neurosci 29:12079\u201312088, doi: 10.1523\/JNEUROSCI.3345-09.2009","journal-title":"J Neurosci"},{"key":"204_CR74","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.neuropharm.2010.01.016","volume":"59","author":"B Bulic","year":"2010","unstructured":"Bulic B, Pickhardt M, Mandelkow EM, Mandelkow E (2010) Tau protein and tau aggregation inhibitors. Neuropharmacology 59:276\u2013289, doi:S0028-3908(10)00030-4","journal-title":"Neuropharmacology"},{"key":"204_CR75","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2174\/156720509789207976","volume":"6","author":"E Chang","year":"2009","unstructured":"Chang E, Honson NS, Bandyopadhyay B, Funk KE, Jensen JR, Kim S, Naphade S, Kuret J (2009) Modulation and detection of tau aggregation with small-molecule ligands. Curr Alzheimer Res 6:409\u2013414","journal-title":"Curr Alzheimer Res"},{"key":"204_CR76","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.expneurol.2009.08.031","volume":"223","author":"KR Brunden","year":"2010","unstructured":"Brunden KR, Ballatore C, Crowe A, Smith AB 3rd, Lee VM, Trojanowski JQ (2010) Tau-directed drug discovery for Alzheimer\u2019s disease and related tauopathies: a focus on tau assembly inhibitors. Exp Neurol 223:304\u2013310, doi: 10.1016\/j.expneurol.2009.08.031","journal-title":"Exp Neurol"},{"key":"204_CR77","doi-asserted-by":"publisher","first-page":"9215","DOI":"10.1002\/anie.200704051","volume":"46","author":"B Bulic","year":"2007","unstructured":"Bulic B, Pickhardt M, Khlistunova I, Biernat J, Mandelkow EM, Mandelkow E, Waldmann H (2007) Rhodanine-based tau aggregation inhibitors in cell models of tauopathy. Angew Chem Int Ed Engl 46:9215\u20139219, doi: 10.1002\/anie.200704051","journal-title":"Angew Chem Int Ed Engl"},{"key":"204_CR78","doi-asserted-by":"publisher","first-page":"10016","DOI":"10.1021\/bi700878g","volume":"46","author":"M Pickhardt","year":"2007","unstructured":"Pickhardt M, Larbig G, Khlistunova I, Coksezen A, Meyer B, Mandelkow EM, Schmidt B, Mandelkow E (2007) Phenylthiazolyl-hydrazide and its derivatives are potent inhibitors of tau aggregation and toxicity in vitro and in cells. Biochemistry 46:10016\u201310023, doi: 10.1021\/bi700878g","journal-title":"Biochemistry"},{"key":"204_CR79","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1016\/j.neurobiolaging.2012.10.024","volume":"34","author":"L Messing","year":"2013","unstructured":"Messing L, Decker JM, Joseph M, Mandelkow E, Mandelkow EM (2013) Cascade of tau toxicity in inducible hippocampal brain slices and prevention by aggregation inhibitors. Neurobiol Aging 34:1343\u20131354, doi: 10.1016\/j.neurobiolaging.2012.10.024","journal-title":"Neurobiol Aging"},{"key":"204_CR80","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/cr.2013.153","volume":"24","author":"AM Cuervo","year":"2014","unstructured":"Cuervo AM, Wong E (2014) Chaperone-mediated autophagy: roles in disease and aging. Cell Res 24:92\u2013104, doi: 10.1038\/cr.2013.153","journal-title":"Cell Res"},{"key":"204_CR81","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.expneurol.2010.11.003","volume":"238","author":"DJ Metcalf","year":"2012","unstructured":"Metcalf DJ, Garcia-Arencibia M, Hochfeld WE, Rubinsztein DC (2012) Autophagy and misfolded proteins in neurodegeneration. Exp Neurol 238:22\u201328, doi: 10.1016\/j.expneurol.2010.11.003","journal-title":"Exp Neurol"},{"key":"204_CR82","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1093\/hmg\/ddp367","volume":"18","author":"M-VM Wang","year":"2009","unstructured":"Wang M-VM, Kruger U, Kaushik S, Wong E, Mandelkow EM, Cuervo AM, Mandelkow E (2009) Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing. Hum Mol Genet 18:4153\u20134170, doi: 10.1093\/hmg\/ddp367","journal-title":"Hum Mol Genet"},{"key":"204_CR83","doi-asserted-by":"crossref","unstructured":"Cardenas-Aguayo MD, Gomez-Virgilio L, DeRosa S, Meraz-Rios MA (2014) The Role of Tau Oligomers in the Onset of Alzheimer\u2019s Disease Neuropathology. ACS Chem Neurosci [Epub ahead of print]. doi:10.1021\/cn500148z","DOI":"10.1021\/cn500148z"},{"key":"204_CR84","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ejphar.2005.02.001","volume":"511","author":"PD Riha","year":"2005","unstructured":"Riha PD, Bruchey AK, Echevarria DJ, Gonzalez-Lima F (2005) Memory facilitation by methylene blue: dose-dependent effect on behavior and brain oxygen consumption. Eur J Pharmacol 511:151\u2013158, doi: 10.1016\/j.ejphar.2005.02.001","journal-title":"Eur J Pharmacol"},{"key":"204_CR85","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3844\/ajptsp.2008.72.79","volume":"3","author":"AK Bruchey","year":"2008","unstructured":"Bruchey AK, Gonzalez-Lima F (2008) Behavioral, Physiological and Biochemical Hormetic Responses to the Autoxidizable Dye Methylene Blue. Am J Pharmacol Toxicol 3:72\u201379","journal-title":"Am J Pharmacol Toxicol"},{"key":"204_CR86","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/0006-2952(93)90072-5","volume":"45","author":"B Mayer","year":"1993","unstructured":"Mayer B, Brunner F, Schmidt K (1993) Inhibition of nitric oxide synthesis by methylene blue. Biochem Pharmacol 45:367\u2013374","journal-title":"Biochem Pharmacol"},{"key":"204_CR87","doi-asserted-by":"publisher","first-page":"541","DOI":"10.2174\/1567201810666131113102037","volume":"11","author":"UK Jinwal","year":"2014","unstructured":"Jinwal UK, Groshev A, Zhang J, Grover A, Sutariya VB (2014) Preparation and characterization of methylene blue nanoparticles for Alzheimer\u2019s disease and other tauopathies. Curr Drug Deliv 11:541\u2013550","journal-title":"Curr Drug Deliv"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-015-0204-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-015-0204-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-015-0204-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-015-0204-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,7]],"date-time":"2022-05-07T14:48:29Z","timestamp":1651934909000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-015-0204-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,10]]},"references-count":87,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["204"],"URL":"https:\/\/doi.org\/10.1186\/s40478-015-0204-4","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,10]]},"assertion":[{"value":"15 April 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"25"}}